The M2 macrophages infiltration of sebaceous tumors is linked to the aggressiveness of tumors but not to the mismatch repair pathway

J Cancer Res Clin Oncol. 2023 Aug;149(9):6445-6454. doi: 10.1007/s00432-023-04629-x. Epub 2023 Feb 10.

Abstract

Purpose: The immune microenvironment of sebaceous neoplasms (SNs) has been poorly explored, especially in benign lesions, and never correlated to the mismatch repair (MMR) status.

Methods: We conducted an immuno-histological study to analyze the immune microenvironment of SNs. A tissue microarray was constructed including sebaceous adenomas (SAs), sebaceomas (Ss) and sebaceous carcinomas (SCs) to performed immuno-histological analysis of T cells, B cells, macrophages, dendritic cells, and expression of Programmed Death-1 (PD-1) and Programmed Death Ligand 1 (PD-L1). An automatized count was performed using the QuPath® software. Composition of the cellular microenvironment was compared to the aggressiveness, the MMR status, and to Muir-Torre syndrome (MTS).

Results: We included 123 SNs (43 SAs, 19 Ss and 61 SCs) for which 71.5% had a dMMR phenotype. A higher infiltration of macrophages (CD68 +) of M2 phenotype (CD163 +) and dendritic cells (CD11c +) was noticed in SCs compared to benign SNs (SAs and Ss). Programmed cell death ligand-1 but not PD-1 was expressed by more immune cells in SCs compared to benign SNs. No difference in the immune cell composition regarding the MMR status, or to MTS was observed.

Conclusion: In SNs, M2 macrophages and dendritic cells infiltrates are associated with the progression and the malignant transformation of tumors. High PD-L1 expression in immune cells in SCs is an argument for the use of immunotherapy by anti-PD1 or PD-L1 in metastatic patients. The lack of correlation between the composition of immune cells in SNs and the MMR status emphasizes the singularity of SNs among MMR-associated malignancies.

Keywords: Dendritic cells; Macrophage; Microenvironment; Microsatellite instability; Muir–Torre; Sebaceoma; Sebaceous adenoma; Sebaceous carcinoma.

MeSH terms

  • B7-H1 Antigen / genetics
  • DNA Mismatch Repair
  • Humans
  • Muir-Torre Syndrome* / genetics
  • Neoplastic Syndromes, Hereditary*
  • Sebaceous Gland Neoplasms* / genetics
  • Sebaceous Gland Neoplasms* / metabolism
  • Sebaceous Gland Neoplasms* / pathology
  • Tumor Microenvironment

Substances

  • B7-H1 Antigen